Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)

Martin Burton* (Corresponding Author), Janet E. Clarkson, Beatriz Goulao, Anne-Marie Glenny, Andrew J. McBain, Anne G.M. Schilder, Katie E. Webster, Helen V Worthington

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of antimicrobial mouthwashes and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection in order to protect the healthcare workers (HCWs) caring for them.

To assess the benefits and harms of antimicrobial mouthwashes and nasal spray in improving outcomes for patients with suspected or confirmed COVID‐19 infection.
Original languageEnglish
Article numberCD013627
Number of pages11
JournalCochrane Database of Systematic Reviews
Volume2020
Issue number5
DOIs
Publication statusPublished - 20 May 2020

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)'. Together they form a unique fingerprint.

  • Cite this